From concerns surrounding regulatory acceptance to defining digital endpoints and deployment plans and digital data collection, there are many factors to consider before incorporating new tools and processes into a clinical trial.
TORONTO (PRWEB) September 25, 2020
Many drug development sponsors are interested in understanding how a digital biomarker strategy can improve patient-centricity their trial. However, may feel uncertain about where – and sometimes even why – to start. From concerns surrounding regulatory acceptance to defining digital endpoints and deployment plans and digital data collection, there are many factors to consider before incorporating new tools and processes into a clinical trial.
This educational webinar is ideal for drug development sponsors that want to learn about the role of digital biomarkers in clinical trials and hear from several thought leaders as they discuss the key concerns with digital biomarker technologies, their implementation and regulatory acceptance. With a focus on strategic design and considerations for creating digital endpoints as part of an overarching deployment plan, the presenters will also cover many of the key pillars in the adoption and implementation of digital devices in a today’s “new normal” with decentralized or hybrid clinical trial elements.
Register today to be a part of this timely and highly relevant discussion that will also offer attendees a chance to pose their own questions and get real-time responses from several thought leaders.
Join Jennifer Goldsack, MChem, MA, MBA, Executive Director, Digital Medicine Society (DiMe), Christian Knaus, Senior Director, Client Development, SnapIoT Inc., Cristina Green, Executive Director, Decentralized Clinical Trials, Covance and Jane Myles , Director, Decentralized Trials Implementation, Covance in a live webinar on Wednesday, October 7, 2020 at 10am EDT (3pm BST/UK).
For more information or to register for this event, visit Defining, Designing and Deploying Digital Biomarkers in Clinical Trials.
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.